GL1X · GenesisL1 explorer

Research workbench

Complex structure of hcmv protease and a peptidomimetic inhibitor

Analyse Complex structure of hcmv protease and a peptidomimetic inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1NKM
Type
protein
Length
440 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Assemblin
EC
3.4.21.97
UniProt
P16753
Ligands
0FP
Pockets
8 · best druggability 0.54

Structure

x-ray diffraction · 2 distinct chains · 36% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAssemblin (EC 3.4.21.97)protein22036% helix, 22% strandP16753
BAssemblin (EC 3.4.21.97)protein22036% helix, 20% strandP16753

Ligands and binding sites

  • 0FP · N-(6-aminohexanoyl)-3-methyl-L-valyl-3-methyl-L-valyl-N~1~-[(2S,3S)-3-hydroxy-4-oxo-4-{[(1R)-1-phenylpropyl]amino}butan-2-yl]-N~4~,N~4~-dimethyl-L-aspartamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1580.540.8816empty
21790.530.7938empty
31230.420.7618empty
4630.380.7914empty
5990.360.7525empty

Interfaces

1 interface between chains.

  • A–B · 1578 Ų buried · 17 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 1NKM · Complex structure of HCMV Protease and a peptidomimetic inhibitor · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.